Robeco Institutional Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
774,160
+147,112
| +23% | +$5.3M | 0.05% | 305 |
|
|
2025
Q1 | $19.5M | Buy |
627,048
+78,287
| +14% | +$2.44M | 0.04% | 337 |
|
|
2024
Q4 | $14M | Buy |
548,761
+43,926
| +9% | +$1.12M | 0.03% | 384 |
|
|
2024
Q3 | $14.3M | Buy |
504,835
+165,440
| +49% | +$4.68M | 0.03% | 386 |
|
|
2024
Q2 | $8.95M | Buy |
339,395
+264,900
| +356% | +$6.99M | 0.02% | 442 |
|
|
2024
Q1 | $2.26M | Buy |
74,495
+24,043
| +48% | +$730K | ﹤0.01% | 660 |
|
|
2023
Q4 | $1.42M | Buy |
50,452
+42,256
| +516% | +$1.19M | ﹤0.01% | 748 |
|
|
2023
Q3 | $222K | Sell |
8,196
-966
| -11% | -$26.2K | ﹤0.01% | 915 |
|
|
2023
Q2 | $282K | Sell |
9,162
-14,399
| -61% | -$443K | ﹤0.01% | 912 |
|
|
2023
Q1 | $849K | Sell |
23,561
-30,867
| -57% | -$1.11M | ﹤0.01% | 796 |
|
|
2022
Q4 | $2.15M | Sell |
54,428
-51,675
| -49% | -$2.04M | 0.01% | 688 |
|
|
2022
Q3 | $4.26M | Buy |
106,103
+30,450
| +40% | +$1.22M | 0.01% | 539 |
|
|
2022
Q2 | $3.18M | Buy |
75,653
+43,027
| +132% | +$1.81M | 0.01% | 585 |
|
|
2022
Q1 | $1.27M | Buy |
32,626
+27,347
| +518% | +$1.07M | ﹤0.01% | 687 |
|
|
2021
Q4 | $210K | Hold |
5,279
| – | – | ﹤0.01% | 839 |
|
|
2021
Q3 | $191K | Hold |
5,279
| – | – | ﹤0.01% | 852 |
|
|
2021
Q2 | $216K | Hold |
5,279
| – | – | ﹤0.01% | 876 |
|
|
2021
Q1 | $231K | Buy |
+5,279
| New | +$231K | ﹤0.01% | 860 |
|